MAPTAC Trademark

Trademark Overview

On Friday, May 24, 2019, a trademark application was filed for MAPTAC with the United States Patent and Trademark Office. The USPTO has given the MAPTAC trademark a serial number of 88445470. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 13, 2023. This trademark is owned by Neon Therapeutics, Inc.. The MAPTAC trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; and consulting services for others in the field of design, planning, and implementation of clinical trials
maptac

General Information

Serial Number88445470
Word MarkMAPTAC
Filing DateFriday, May 24, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2019

Trademark Statements

Pseudo MarkMAP TAC; MAP TACK
Goods and ServicesConducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; and consulting services for others in the field of design, planning, and implementation of clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 10, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioNTech US Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameNeon Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameNeon Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, March 13, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 13, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 2, 2022SOU EXTENSION 5 GRANTED
Thursday, July 14, 2022SOU EXTENSION 5 FILED
Thursday, July 14, 2022SOU TEAS EXTENSION RECEIVED
Thursday, January 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 25, 2022SOU EXTENSION 4 GRANTED
Tuesday, January 25, 2022SOU EXTENSION 4 FILED
Tuesday, January 25, 2022SOU TEAS EXTENSION RECEIVED
Monday, January 3, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, December 28, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 28, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, June 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 17, 2021SOU EXTENSION 3 GRANTED
Thursday, June 17, 2021SOU EXTENSION 3 FILED
Thursday, June 17, 2021SOU TEAS EXTENSION RECEIVED
Friday, February 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 3, 2021SOU EXTENSION 2 GRANTED
Wednesday, February 3, 2021SOU EXTENSION 2 FILED
Wednesday, February 3, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, August 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 18, 2020SOU EXTENSION 1 GRANTED
Tuesday, August 4, 2020SOU EXTENSION 1 FILED
Monday, August 17, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 4, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, February 4, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 5, 2019ASSIGNED TO LIE
Wednesday, October 30, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 30, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, October 30, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 30, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, October 30, 2019EXAMINERS AMENDMENT -WRITTEN
Sunday, August 18, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, August 18, 2019NON-FINAL ACTION E-MAILED
Sunday, August 18, 2019NON-FINAL ACTION WRITTEN
Wednesday, August 14, 2019ASSIGNED TO EXAMINER
Monday, June 10, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 28, 2019NEW APPLICATION ENTERED

Related Keywords

maptac research development pharmaceutical field services pharmaceuticals cancer trials clinical conducting